联合使用β-干扰素和阿托伐他汀可能会增加多发性硬化症的疾病活动度。 - Suppr | 超能文献

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.

作者信息

Salvatore Elena, Morra Vincenzo Brescia, Orefice Giuseppe

出版信息

Neurology. 2009 Sep 29;73(13):1078; author reply 1078-9. doi: 10.1212/WNL.0b013e3181ab6e08.

DOI:10.1212/WNL.0b013e3181ab6e08

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.联合使用β-干扰素和阿托伐他汀可能会增加多发性硬化症的疾病活动度。

Neurology. 2009 Sep 29;73(13):1078; author reply 1078-9. doi: 10.1212/WNL.0b013e3181ab6e08.

2

Atorvastatin does not alter interferon Beta-induced changes of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in patients with multiple sclerosis.阿托伐他汀不会改变干扰素β诱导的多发性硬化症患者血清基质金属蛋白酶9和金属蛋白酶组织抑制剂1的变化。

Arch Neurol. 2008 May;65(5):672-4. doi: 10.1001/archneur.65.5.672.

3

Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis.阿托伐他汀可降低多发性硬化症患者的高敏C反应蛋白水平。

Mult Scler. 2008 Aug;14(7):981-4. doi: 10.1177/1352458508091368. Epub 2008 Jun 23.

4

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.联合使用β-干扰素和阿托伐他汀可能会增加多发性硬化症的疾病活动度。

Neurology. 2009 Jun 2;72(22):1965; author reply 1965-6. doi: 10.1212/01.wnl.0000349667.27301.c8.

5

Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy.阿托伐他汀联合干扰素验证（ACTIVE）在复发缓解型活跃多发性硬化症患者中的疗效：一项联合治疗的纵向对照试验。

Mult Scler. 2010 Apr;16(4):450-4. doi: 10.1177/1352458509358909. Epub 2010 Feb 11.

6

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.联合使用β-干扰素和阿托伐他汀可能会增加多发性硬化症的疾病活动度。

Neurology. 2008 Oct 28;71(18):1390-5. doi: 10.1212/01.wnl.0000319698.40024.1c. Epub 2008 Jun 4.

7

Intensive lipid lowering with atorvastatin in coronary disease.阿托伐他汀强化降脂治疗冠心病

N Engl J Med. 2005 Jul 7;353(1):93-6; author reply 93-6.

8

Risk factors for rhabdomyolysis with simvastatin and atorvastatin.辛伐他汀和阿托伐他汀所致横纹肌溶解症的危险因素。

Drug Saf. 2006;29(12):1191; author reply 1191-2. doi: 10.2165/00002018-200629120-00009.

9

Depression in multiple sclerosis associated with interferon beta-1a (Rebif).与干扰素β-1a（Rebif）相关的多发性硬化症中的抑郁症。

Can J Psychiatry. 2002 Sep;47(7):686. doi: 10.1177/070674370204700720.

10

Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis.口服大剂量阿托伐他汀治疗复发缓解型多发性硬化症。

PLoS One. 2008 Apr 9;3(4):e1928. doi: 10.1371/journal.pone.0001928.

引用本文的文献

1

Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020.多发性硬化症神经保护和神经再生治疗策略的失败、中断或不确定的临床试验：2015-2020 年更新。

Drugs. 2021 Jun;81(9):1031-1063. doi: 10.1007/s40265-021-01526-w. Epub 2021 Jun 4.